Invicta Diagnostic IPO GMP: Day 1 IPO Live Updates

Posted by : sachet | Mon Dec 01 2025

The Invicta Diagnostic IPO GMP is ₹0 as of 1st December 2025. It is a bookbuilding IPO of ₹28.12 crores. This is an entirely fresh issue of 33,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 8th December 2025. The face value of Invicta Diagnostic IPO shares is ₹10 per share, and the IPO price band is ₹80 to ₹85 per share. Retail investors can bid for a minimum of 2 lots of 3,200 shares worth ₹2,72,000.

Table of Contents

Invicta Diagnostic IPO GMP Grey Market Premium

As of 1st December 2025, the Invicta Diagnostic IPO GMP stands at ₹0 per share. Thus, the estimated listing price would be ₹85. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Invicta Diagnostic IPO GMP updates.

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Listing Gains
1-12-2025	₹85.00	₹0.00	₹85.00	0.00%
30-11-2025	₹85.00	₹0.00	₹85.00	0.00%
29-11-2025	₹85.00	₹0.00	₹85.00	0.00%
28-11-2025	₹85.00	₹0.00	₹85.00	0.00%
27-11-2025	₹85.00	₹0.00	₹85.00	0.00%
26-11-2025	₹85.00	₹0.00	₹85.00	0.00%

Invicta Diagnostic IPO Details

IPO Open Date	1st December 2025
IPO Close Date	3rd December 2025
IPO Allotment Date	4th December 2025
Refund Initiation	5th December 2025
Face Value	₹10 per share
Price Band	₹80 to ₹85 per share
Lot Size	1,600 Shares
Issue Size	33,08,800 shares(aggregating up to ₹28.12 Cr)
Issue Type	Bookbuilding IPO
Listing At	NSE and SME
Listing Date	8th December 2025

Explanation

Invicta Diagnostic IPO: Invicta Diagnostic IPO Limited has declared an issue price band of ₹80.00 to ₹85.00 per share. With this IPO, the company allows retail investors to bid for at least two lots of 3,200 shares, each worth ₹2,72,000. The face value of Invicta Diagnostic IPO Limited shares is ₹10 per share. The shares of Invicta Diagnostic IPO Limited will be listed on BSE and SME on its tentative listing day, 8th December 2025. Scroll down to check GMP updates and Invicta Diagnostic IPO reviews.

Invicta Diagnostic IPO Objectives

The primary aim of the Invicta Diagnostic IPO is to raise ₹28.12 crores. On the other hand, Invicta Diagnostic has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Invicta Diagnostic IPO.

Funding capital expenditure for the purchase of medical equipment towards the establishment of five new diagnostic centres in Maharashtra
General Corporate purposes

Invicta Diagnostic IPO Registrar

According to recent updates, Bigshare Services Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Invicta Diagnostic IPO GMP, allotment, or refund, please contact the investor relations team at Bigshare Services Private Limited, ipo@bigshareonline.com or +91-22-6263 8200.

Invicta Diagnostic IPO Review

The Invicta Diagnostic IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Invicta Diagnostic Limited’s revenue soared by 90% from ₹15.90 crores in March 2024 to ₹30.18 crores in March 2025. Moreover, the company’s PAT increased by 30% from ₹3.81 crores in March 2024 to ₹4.93 crores in March 2025. Investors can analyse other relevant factors and make a decision accordingly.

Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for Invicta Diagnostic IPO or not.

Invicta Diagnostic IPO Limited Technicals

Key Indicators	Value
PE Ratio (Price-to-Earnings)	15.97
EPS (Earnings Per Share)	5.32
RoNW	36.25%
ROCE	42.00%
ROE	44.28%
EBITDA Margin	30.57%
Price to Book Value	5.26
Market Capitalisation	₹106.86 Cr.

The P/E ratio of Invicta Diagnostic Limited’s shares is 15.97, and its Earnings Per Share (EPS) is 5.32. Thus, the Invicta Diagnostic Limited IPO can deliver gains on its tentative listing day, 8th December 2025

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Invicta Diagnostic IPO Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.

Indicators	Pre-IPO	Post-IPO
PE Ratio	15.97	13.08
EPS	5.32	13.08

FAQs on Invicta Diagnostic IPO

What is the Invicta Diagnostic IPO GMP?

Currently, on 1st December 2025, the Invicta Diagnostic IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹85 per share.

What is the issue price of Invicta Diagnostic IPO?

The Invicta Diagnostic IPO issue price band is set at ₹80 to ₹85 per share. Retail investors can apply for a minimum of 2 lots consisting of 3,200 shares worth ₹2,72,000. Moreover, HNIs are required to bid for a minimum of 3 lots (4,800 shares) worth ₹4,08,000.

Who is the registrar of Invicta Diagnostic IPO?

Bigshare Services Pvt Limited is the registrar for the Invicta Diagnostic IPO, awaiting to manage the allotment process and initiation of refunds. For any queries regarding the Invicta Diagnostic allotment and refund, you can contact Bigshare Services Pvt. Ltd. at ipo@bigshareonline.com or +91-22-6263 8200.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Invicta Diagnostic IPO, download the Invicta Diagnostic IPO RHP and Invicta Diagnostic IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.